Advanced Life Sciences’ Once-Daily Cethromycin Non-Inferior To Biaxin In First Pivotal Trial
This article was originally published in The Pink Sheet Daily
Executive Summary
NDA for cethromycin to treat community-acquired pneumonia could be filed in second half of 2007, President John Flavin tells “The Pink Sheet” DAILY.